PMID: 239131May 1, 1975Paper

The animal pharmacology of drugs used in the treatment of migraine

The Journal of Pharmacy and Pharmacology
J R Fozard


No abstract listed.


Mar 18, 1972·Lancet·M Sandler
Oct 1, 1973·Acta Physiologica Scandinavica·T HökfeltO Johansson
Feb 1, 1973·The Journal of Pharmacy and Pharmacology·P A van Zwieten
Apr 5, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·A Csongrady, W Kobinger
Jan 1, 1974·European Journal of Pharmacology·M Laubie, H Schmitt
Jul 1, 1974·British Journal of Pharmacology·E Müller-Schweinitzer, E Stürmer
Feb 8, 1969·Lancet
Aug 9, 1969·Lancet·E Zaimis, E Hanington
Jan 1, 1968·Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie·R SalzmannH Weidmann
May 1, 1970·European Journal of Pharmacology·H KluppH Teichmann
Apr 1, 1972·British Journal of Pharmacology·F KaticR D Lowe
Feb 1, 1968·European Journal of Pharmacology·J R Fozard, G D Leach
Jan 1, 1969·European Journal of Pharmacology·S Guimarães, W Osswald
Jan 1, 1971·European Journal of Pharmacology·A M AutretN Pétillot
Jan 1, 1972·Acta Neurologica Scandinavica·O Sjaastad, P Stensrud
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·K Starke
Mar 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·M Hamberg, B Samuelsson
Aug 1, 1972·Journal of Neurology, Neurosurgery, and Psychiatry·H Jacobs
Jun 29, 1974·British Medical Journal·T E Wideroe, T Vigander
Aug 1, 1972·The Australian Journal of Experimental Biology and Medical Science·R L Hodge, S M Robinson
Apr 1, 1973·British Journal of Pharmacology·J M Armstrong, A L Boura
Aug 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·J D Gomersall, A Stuart
Jul 26, 1974·Nature·M SandlerE Hanington
Jul 1, 1974·European Journal of Pharmacology·E Müller-Schweinitzer
Jul 18, 1970·British Medical Journal·W E Waters
Jan 1, 1970·Acta Neurologica Scandinavica·U Larsson-Cohn, P O Lundberg
Aug 1, 1971·Neurology·B W Somerville
Aug 1, 1971·British Journal of Pharmacology·J N Cumings, B P Hilton
Sep 1, 1971·British Journal of Pharmacology·L O Farnebo, B Hamberger
May 1, 1967·Archives of Neurology·M AnthonyJ W Lance

❮ Previous
Next ❯


Apr 25, 1979·Psychopharmacology·E PrzegalińskiJ Siwanowicz
Sep 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M A BlackshearE Sanders-Bush
Jun 18, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Fozard, M G Palfreyman
Jan 1, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Fozard, A T Ali
Jan 1, 1991·Journal of Neurology·P P Humphrey
Jan 1, 1991·Journal of Neurology·E J Mylecharane
Aug 1, 1987·Neurochemical Pathology·R Saunders, L A Horrocks
Feb 21, 1977·European Journal of Pharmacology·S A Darwish, B L Furman
Dec 20, 1979·European Journal of Pharmacology·J C Lamar, J E Hardebo
Jul 31, 1985·European Journal of Pharmacology·A G Ramage
Dec 1, 1986·Pharmacology, Biochemistry, and Behavior·R YoungR A Glennon
Sep 28, 1991·Lancet·P J GoadsbyJ W Lance
Jan 1, 1983·Social Science & Medicine·R M FitzpatrickO Harvard-Watts
Aug 18, 1979·Lancet·H HakkarainenJ Parantainen
May 1, 1992·Journal of Internal Medicine·P Kangasniemi, R Kaaja
Oct 1, 1976·British Journal of Pharmacology·E ApperleyG P Levy
Apr 1, 1978·Postgraduate Medical Journal·E S Johnson
Jan 1, 1990·Annals of the New York Academy of Sciences·P P HumphreyE T Whalley
Nov 1, 1981·British Journal of Pharmacology·J L BlackE J Mylecharane
Dec 1, 1984·Australian and New Zealand Journal of Medicine·M Anthony
Jan 1, 1981·International Journal of Aging & Human Development·N W Denney
Jan 1, 1985·International Journal of Aging & Human Development·M Bagshaw, M Adams
Apr 30, 2016·Cephalalgia : an International Journal of Headache·Daniel Segelcke, Karl Messlinger
May 1, 1979·Stroke; a Journal of Cerebral Circulation·M J KupersmithN E Chase
Aug 1, 1978·The Journal of Pharmacy and Pharmacology·R P Forsyth, P R Saxena
Oct 1, 1979·Scottish Medical Journal·D G Lambie
May 1, 1985·Cephalalgia : an International Journal of Headache·G Burnstock
Nov 4, 1978·The Medical Journal of Australia·B Berde

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Australian Journal of Experimental Biology and Medical Science
R L Hodge, S M Robinson
JAMA : the Journal of the American Medical Association
Archives of Neurology
M AnthonyJ W LANCE
© 2021 Meta ULC. All rights reserved